The study conducted by Schwartz et al. revealed that Ras/MAPK pathway mutations, alterations in RUNX1 or TP53, and KMT2A rearrangements were the most frequently associated with pediatric AML-pCT [6]. The gene discussed is RUNX1; the disease is acute myeloid leukemia.